70 results on '"Zheng, Chao-Hui"'
Search Results
2. Prognostic value of preoperative sarcopenia in gastric cancer: A 10-year follow-up study
3. Development and Validation of a Machine Learning Model for Predicting the Prognosis of Older Patients with Gastric Cancer: A Retrospective, Population-Based Cohort Study In China
4. Long-term prognostic benefit of adjuvant chemotherapy for patients with hepatoid adenocarcinoma of the stomach after radical resection: A national multicenter study
5. A scoring model for predicting early recurrence of gastric cancer with normal preoperative tumor markers: A multicenter study
6. Randomized controlled trial in gastric or gastroesophageal junction adenocarcinoma undergoing systemic therapy over two decades
7. The GLIM criteria as an effective tool for survival prediction in gastric cancer patients
8. Neoadjuvant Camrelizumab and Apatinib Combined with Chemotherapy for Locally Advanced Gastric Cancer: A Randomized, Multicenter, Open-Label, Phase 2 Trial
9. NUAK1 Activates STAT5/GLI1/SOX2 Signaling to Enhance Cancer Stem Cell Expansion and Drives Chemoresistance in Gastric Cancer
10. Textbook outcome, chemotherapy compliance, and prognosis after radical gastrectomy for gastric cancer: A large sample analysis
11. Postoperative follow-up for gastric cancer needs to be individualized according to age, tumour recurrence pattern, and recurrence time
12. A novel hematological classifier predicting chemotherapy benefit and recurrence hazard for locally advanced gastric cancer A multicenter IPTW analysis
13. Assessment of the short-term outcomes of laparoscopic gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: A prospective single-armed clinical trial
14. Application of an artificial neural network for predicting the potential chemotherapy benefit of patients with gastric cancer after radical surgery
15. Clinical implications of Indocyanine Green Fluorescence Imaging-Guided laparoscopic lymphadenectomy for patients with gastric cancer: A cohort study from two randomized, controlled trials using individual patient data
16. WITHDRAWN: FOXC1 modulates stem-like cell properties and chemoresistance through hedgehog and EMT signaling in gastric adenocarcinoma
17. Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: A multicenter, international study
18. Prognostic analysis of patients with intra-abdominal infectious complications after laparoscopic-assisted and open radical gastrectomy for gastric cancer – A propensity score-matching analysis
19. Clinical Implications of Indocyanine Green Fluorescence Imaging‑Guided Laparoscopic Lymphadenectomy for Patients With Gastric Cancer: Pooled Analysis From Two Randomized, Controlled Trials Using Individual Patient Data
20. BMI-adjusted prognosis of signet ring cell carcinoma in patients undergoing radical gastrectomy for gastric adenocarcinoma
21. Laparoscopic Radical Gastrectomy for Gastric Cancer: Long-Term Outcome and Critical Analysis of 10-Year Experience in a Teaching Center
22. Prognostic value of a new staging system based on the retrieved number and metastatic rate of LNs in gastric cancer with ≤15 retrieved LNs
23. Advances in laparoscopic surgery for the treatment of advanced gastric cancer in China
24. Implications for restaging in gastric cancer with peritoneal metastasis based on the 15th Japanese Classification of Gastric Carcinoma: An analysis from a comprehensive center
25. “Five-step” laparoscopic lymph node dissection for remnant gastric cancer following Billroth-II gastrectomy: A safe and feasible procedure
26. Circular RNA circ-RanGAP1 regulates VEGFA expression by targeting miR-877–3p to facilitate gastric cancer invasion and metastasis
27. Safety and Feasibility of Laparoscopic Spleen-Preserving Splenic Hilar Lymphadenectomy During Total Gastrectomy for Advanced Proximal Gastric Cancer: A Randomized Clinical Trial
28. Efficacy and Safety of Apatinib Combined with S-1 Plus Oxaliplatin as Neoadjuvant Treatment for Locally Advanced Gastric Cancer: A Multicenter, Prospective Study
29. Association of the age-adjusted Charlson Comorbidity Index and systemic inflammation with survival in gastric cancer patients after radical gastrectomy
30. Pathological features and survival analysis of gastric cancer patients with positive surgical margins: A large multicenter cohort study
31. Development and external validation of a nomogram for predicting the conditional probability of survival after D2 lymphadenectomy for gastric cancer: A multicentre study
32. A novel prognosis prediction model after completion gastrectomy for remnant gastric cancer: Development and validation using international multicenter databases
33. A prediction model for potential intraoperative laparoscopic hemostasis in spleen-preserving No. 10 lymphadenectomy for proximal gastric cancer
34. Is the AJCC TNM staging system still appropriate for gastric cancer patients survival after 5 years?
35. Circular RNA hsa_circ_0001368 suppresses the progression of gastric cancer by regulating miR-6506–5p/FOXO3 axis
36. The prognostic value of a Surgical Outcome Risk Tool in patients after radical gastrectomy for gastric cancer and its guiding significance for postoperative chemotherapy
37. Robotic spleen-preserving splenic hilar lymphadenectomy for advanced proximal gastric cancer: A feasible and simplified procedure
38. A long-term conditional survival analysis for gastric cancer based on 7th and 8th TNM classification in Eastern and Western populations
39. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database
40. Which staging system better predicts 10-year survival for gastric cancer? A study using an international multicenter database
41. Prediction of Conditional Probability of Survival After Surgery for Gastric Cancer: A Study Based on Eastern and Western Large Data Sets
42. Preoperative lymph node size is helpful to predict the prognosis of patients with stage III gastric cancer after radical resection
43. Comparison of 3D laparoscopic gastrectomy with a 2D procedure for gastric cancer: A phase 3 randomized controlled trial
44. Safety and Feasibility of Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Locally Advanced Upper Third Gastric Cancer: A Phase II Prospective, Multi-Institution Clinical Trial (CLASS-04)
45. Is it necessary to dissect the posterior lymph nodes along the splenic vessels during total gastrectomy with D2 lymphadenectomy for advanced gastric cancer?
46. The effectiveness of the 8th American Joint Committee on Cancer TNM classification in the prognosis evaluation of gastric cancer patients: A comparative study between the 7th and 8th editions
47. Huang's three-step maneuver shortens the learning curve of laparoscopic spleen-preserving splenic hilar lymphadenectomy
48. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction
49. The preoperative blood lymphocyte-to-monocyte ratio acts as a superior prognostic factor and predicts tumor metastasis in gastric neuroendocrine neoplasms after surgery
50. Optimal extent of abdominal lymph node dissection for advanced Siewert type II and III esophagogastric junction carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.